Cerebral Therapeutics
A clinical-stage pharmaceutical company in Colorado that focuses on treatments for refractory epilepsy.
5
Funding Rounds
$93.6m
Money raised
Overview
A clinical-stage pharmaceutical company in Colorado that focuses on treatments for refractory epilepsy.
- Website:
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Da**** Ab**** | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Cerebral Therapeutics has raised a total of $47.8m in funding over 5 rounds.
Key Insights:
- Cerebral Therapeutics Series C round, June 28, 2022: $40m
- Cerebral Therapeutics Series A round, March 2019: $7.8m
- Cerebral Therapeutics Inc funding round, March 2019: $7.8m
- Cerebral Therapeutics, Inc funding round, June 2018: $3m
- Cerebral Therapeutics, Inc. funding round, January 2020: $35m
Cerebral Therapeutics Series C round, June 28, 2022
$40m
Cerebral Therapeutics Series A round, March 2019
$7.8m
Cerebral Therapeutics Inc funding round, March 2019
$7.8m
Cerebral Therapeutics, Inc funding round, June 2018
$3m
Cerebral Therapeutics, Inc. funding round, January 2020
$35m
Industries
Cerebral Therapeutics is active in the following industries: